OT: Nerds chatting [Bioanalytics]

posted by nobody – 2019-03-28 12:14 (1827 d 23:45 ago) – Posting: # 20101
Views: 5,248

...and even worse (re Danish footer)

The FDA ordered AbbVie to stop recruiting multiple myeloma patients for a Phase III trial of its anti-cancer drug Venclexta/Venclyxto.

Forty-one out of 194 patients taking AbbVie’s Venclexta (venetoclax) in the company’s trial have died, the FDA found, nearly twice the percent of the patients in the trial’s placebo arm.

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
128 visitors (0 registered, 128 guests [including 10 identified bots]).
Forum time: 12:00 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5